Cargando…

Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease

AIM: To investigate the contribution of unaffected cardiomyocytes in Fabry disease cardiomyopathy. FINDINGS: Left ventricular (LV) endomyocardial biopsies from twenty-four females (mean age 53 ± 11 ys) with Fabry disease cardiomyopathy were studied. Diagnosis of FD was based on the presence of patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimenti, Cristina, Verardo, Romina, Frustaci, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037917/
https://www.ncbi.nlm.nih.gov/pubmed/33838691
http://dx.doi.org/10.1186/s13023-021-01803-7
_version_ 1783677255320338432
author Chimenti, Cristina
Verardo, Romina
Frustaci, Andrea
author_facet Chimenti, Cristina
Verardo, Romina
Frustaci, Andrea
author_sort Chimenti, Cristina
collection PubMed
description AIM: To investigate the contribution of unaffected cardiomyocytes in Fabry disease cardiomyopathy. FINDINGS: Left ventricular (LV) endomyocardial biopsies from twenty-four females (mean age 53 ± 11 ys) with Fabry disease cardiomyopathy were studied. Diagnosis of FD was based on the presence of pathogenic GLA mutation, Patients were divided in four groups according with LV maximal wall thickness (MWT): group 1 MWT ≤ 10.5 mm, group 2 MWT 10.5–15 mm, group 3 MWT 16–20 mm, group 4 MWT > 20 mm. At histology mosaic of affected and unaffected cardiomyocytes was documented. Unaffected myocytes’ size ranged from normal to severe hypertrophy. Hypertrophy of unaffected cardiomyocytes correlated with severity of MWT (p < 0.0001, Sperman r 0,95). Hypertrophy of unaffected myocytes appear to concur to progression and severity of FDCM. It is likely a paracrine role from neighboring affected myocytes.
format Online
Article
Text
id pubmed-8037917
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80379172021-04-12 Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease Chimenti, Cristina Verardo, Romina Frustaci, Andrea Orphanet J Rare Dis Letter to the Editor AIM: To investigate the contribution of unaffected cardiomyocytes in Fabry disease cardiomyopathy. FINDINGS: Left ventricular (LV) endomyocardial biopsies from twenty-four females (mean age 53 ± 11 ys) with Fabry disease cardiomyopathy were studied. Diagnosis of FD was based on the presence of pathogenic GLA mutation, Patients were divided in four groups according with LV maximal wall thickness (MWT): group 1 MWT ≤ 10.5 mm, group 2 MWT 10.5–15 mm, group 3 MWT 16–20 mm, group 4 MWT > 20 mm. At histology mosaic of affected and unaffected cardiomyocytes was documented. Unaffected myocytes’ size ranged from normal to severe hypertrophy. Hypertrophy of unaffected cardiomyocytes correlated with severity of MWT (p < 0.0001, Sperman r 0,95). Hypertrophy of unaffected myocytes appear to concur to progression and severity of FDCM. It is likely a paracrine role from neighboring affected myocytes. BioMed Central 2021-04-10 /pmc/articles/PMC8037917/ /pubmed/33838691 http://dx.doi.org/10.1186/s13023-021-01803-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Chimenti, Cristina
Verardo, Romina
Frustaci, Andrea
Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title_full Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title_fullStr Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title_full_unstemmed Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title_short Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
title_sort hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with fabry disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037917/
https://www.ncbi.nlm.nih.gov/pubmed/33838691
http://dx.doi.org/10.1186/s13023-021-01803-7
work_keys_str_mv AT chimenticristina hypertrophyofunaffectedcardiomyocytescorrelateswithseverityofcardiomyopathyinfemalepatientswithfabrydisease
AT verardoromina hypertrophyofunaffectedcardiomyocytescorrelateswithseverityofcardiomyopathyinfemalepatientswithfabrydisease
AT frustaciandrea hypertrophyofunaffectedcardiomyocytescorrelateswithseverityofcardiomyopathyinfemalepatientswithfabrydisease